Association between cystatin C and diabetic retinopathy among type 2 diabetic patients in China: a Meta-analysis.

Nan Yang, Yun-Fei Lu, Xiao Yang, Kui Jiang, Ai-Min Sang, Hui-Qun Wu
Author Information
  1. Nan Yang: Department of Medical Informatics, Medical School of Nantong University, Nantong 226001, Jiangsu Province, China.
  2. Yun-Fei Lu: Department of Medical Informatics, Medical School of Nantong University, Nantong 226001, Jiangsu Province, China.
  3. Xiao Yang: Department of Medical Informatics, Medical School of Nantong University, Nantong 226001, Jiangsu Province, China.
  4. Kui Jiang: Department of Medical Informatics, Medical School of Nantong University, Nantong 226001, Jiangsu Province, China.
  5. Ai-Min Sang: Department of Ophthalmology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
  6. Hui-Qun Wu: Department of Medical Informatics, Medical School of Nantong University, Nantong 226001, Jiangsu Province, China.

Abstract

AIM: To explore the correlation between cystatin C (Cys-C) and diabetic retinopathy (DR) in those patients with type 2 diabetes mellitus (DM) in China.
METHODS: Articles were collected from China National Knowledge Infrastructure (CNKI), Wanfang, VIP, PubMed, EMBASE, Cochrane Library, Clinical Trials.gov, and Google Scholar. Quality and risk of bias within included studies was assessed using the Newcastle-Ottawa scale (NOS). Heterogeneity was determined by using Cochran's -test and Higgins statistics. Mean differences (MDs) and 95% confidence intervals (CIs) of Cys-C within the diabetes without retinopathy (DWR) and DR, DWR and non-proliferative diabetic retinopathy (NPDR), NPDR and proliferative diabetic retinopathy (PDR) were collected by using random-effects model because of high heterogeneity. Meta-analysis was conducted based on 23 articles of 2331 DR including NPDR and PDR patients and 2023 DWR patients through Review Manager 5.3. Subgroup analyses were also performed according to DM duration, body mass index (BMI), total cholesterol (TC), total triglycerides (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C), sample origins and methods. Publication bias was assessed by the funnel plot.
RESULTS: Cys-C level in DR patients was increased compared with that of DWR (total MD: 0.69, 95%CI: 0.41 to 0.97, =4.79, <0.01). Besides, the synthesized results of the studies showed the similar findings in the DWR NPDR group (total MD: 0.29, 95%CI 0.20 to 0.39, =6.02, <0.01) and the NPDR PDR group (total MD: 0.63, 95%CI 0.43 to 0.82, =6.33, <0.01). Heterogeneity of most of the subgroup analyses was still obvious ( ≥50%, <0.1). Forest plots of different subgroups indicated that there was a slight increase of Cys-C during the period between DWR and DR, DWR and NPDR, NPDR and PDR. Funnel plot showed that there was no significant publication bias.
CONCLUSION: The elevated Cys-C is closely related with DR and probably plays a critical role in its progression.

Keywords

References

  1. Eye (Lond). 2004 Oct;18(10):963-83 [PMID: 15232600]
  2. BMC Nephrol. 2008 Aug 05;9:9 [PMID: 18681974]
  3. Eye (Lond). 2009 Jul;23(7):1496-508 [PMID: 19444297]
  4. Diabetes. 1998 Mar;47(3):445-9 [PMID: 9519752]
  5. Kidney Blood Press Res. 2016;41(6):919-928 [PMID: 27889768]
  6. Kidney Int Suppl. 2000 Sep;77:S113-9 [PMID: 10997700]
  7. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S451-S454 [PMID: 28420575]
  8. Exp Clin Endocrinol Diabetes. 2020 May;128(5):319-324 [PMID: 30149416]
  9. Immunol Cell Biol. 2015 May-Jun;93(5):442-51 [PMID: 25643616]
  10. JAMA Ophthalmol. 2014 Aug;132(8):922-8 [PMID: 24809869]
  11. Arch Oral Biol. 1989;34(4):301-5 [PMID: 2597024]
  12. Exp Diabetes Res. 2007;2007:95103 [PMID: 18274606]
  13. Panminerva Med. 2018 Dec;60(4):151-155 [PMID: 29792017]
  14. Hum Genet. 1989 Jun;82(3):223-6 [PMID: 2567273]
  15. Eur Respir J. 1998 Nov;12(5):1033-9 [PMID: 9863993]
  16. Vision Res. 2017 Oct;139:108-114 [PMID: 28601428]
  17. J Am Coll Cardiol. 2016 Aug 30;68(9):934-45 [PMID: 27561768]
  18. Cell Death Dis. 2017 Jun 1;8(6):e2854 [PMID: 28569795]
  19. Diabetes Res Clin Pract. 2019 Nov;157:107843 [PMID: 31518657]
  20. Br J Ophthalmol. 2020 Aug 27;: [PMID: 32855165]
  21. Diabetes. 2006 Sep;55(9):2401-11 [PMID: 16936187]
  22. Am J Med. 2005 Dec;118(12):1416 [PMID: 16378798]
  23. J Biol Chem. 1986 Aug 25;261(24):11282-9 [PMID: 3488317]
  24. Clin Exp Ophthalmol. 2016 May;44(4):260-77 [PMID: 26716602]
  25. Diabet Med. 2019 Apr;36(4):424-433 [PMID: 30474144]
  26. Mol Biol Cell. 2005 Aug;16(8):3488-500 [PMID: 15901832]
  27. Diabetes Care. 2014 Apr;37(4):1002-8 [PMID: 24271191]
  28. Am J Kidney Dis. 2002 Aug;40(2):221-6 [PMID: 12148093]
  29. Lancet. 2010 Jul 10;376(9735):124-36 [PMID: 20580421]
  30. Diabetes Metab J. 2018 Dec;42(6):513-518 [PMID: 30398035]

Word Cloud

Created with Highcharts 10.0.00DWRNPDRdiabeticretinopathyDRCCys-CpatientstotalPDR<0cystatinbiasusingMeta-analysisMD:01type2diabetesDMChinacollectedwithinstudiesassessedHeterogeneityanalyseslipoproteinplotshowedgroup95%CI=6AIM:explorecorrelationmellitusMETHODS:ArticlesNationalKnowledgeInfrastructureCNKIWanfangVIPPubMedEMBASECochraneLibraryClinicalTrialsgovGoogleScholarQualityriskincludedNewcastle-OttawascaleNOSdeterminedCochran's-testHigginsstatisticsMeandifferencesMDs95%confidenceintervalsCIswithoutnon-proliferativeproliferativerandom-effectsmodelhighheterogeneityconductedbased23articles2331including2023ReviewManager53SubgroupalsoperformedaccordingdurationbodymassindexBMIcholesterolTCtriglyceridesTGlow-densityLDL-Chigh-densityHDL-CsampleoriginsmethodsPublicationfunnelRESULTS:levelincreasedcompared6995%CI:4197=479Besidessynthesizedresultssimilarfindings2920390263438233subgroupstillobvious≥50%1ForestplotsdifferentsubgroupsindicatedslightincreaseperiodFunnelsignificantpublicationCONCLUSION:elevatedcloselyrelatedprobablyplayscriticalroleprogressionAssociationamongChina:

Similar Articles

Cited By